Communicable Diseases  >>  human allogeneic myeloid progenitor cells (CLT-008)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
human allogeneic myeloid progenitor cells (CLT-008) / Cellerant Therap
NCT02282215: Safety and Efficacy of Human Myeloid Progenitor Cells (CLT-008) During Chemotherapy for Acute Myeloid Leukemia

Completed
2
163
US
CLT-008, human allogeneic myeloid progenitor cells (hMPC), romyelocel-L, G-CSF, Neupogen (filgrastim), granulocyte colony-stimulating factor, Zarxio, Granix (tbo-filgrastim)
Cellerant Therapeutics, Department of Health and Human Services
Acute Myeloid Leukemia, Neutropenia, Infection
09/17
09/17

Download Options